AbCellera Biologics Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was USD 12.19 million compared to USD 316.58 million a year ago. Net loss was USD 40.11 million compared to net income of USD 168.57 million a year ago.

Basic loss per share from continuing operations was USD 0.14 compared to basic earnings per share from continuing operations of USD 0.59 a year ago. Diluted loss per share from continuing operations was USD 0.14 compared to diluted earnings per share from continuing operations of USD 0.54 a year ago.